Pilot study: asymptomatic hyperuricemia patients with obesity and nonalcoholic fatty liver disease have increased risk of double contour sign.

Conclusions: Asymptomatic hyperuricemia patients with class II obesity and NAFLD had increased risk of DCS. Determining the presence of crystal deposition, such as DCS, among patients with asymptomatic hyperuricemia might help determine whether early pharmacologic intervention is needed, especially with severe obesity or NAFLD. PMID: 31181878 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31181878?dopt=Abstract

Source: The Korean Journal of Internal Medicine - June 12, 2019 Category: Internal Medicine Authors: Min HK, Cho H, Park SH Tags: Korean J Intern Med Source Type: research